ConductScience.org, home

Paper3928803

Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Herrmann F and 3 others. J Exp Med, 1985. Cited by 309 papers, by iCite.

Cite this record

ConductScience Library. Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells. Papers, record 3928803. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3928803

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.
PubMed
Journal
J Exp Med
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
309
iCite
Relative citation ratio, by iCite
8.17
iCite
Revised in PubMed
2019-05-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Herrmann FF
2Cannistra SAS A
3Levine HH
4Griffin JDJ D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interferon-gammaMajor topic
Interleukin-2Major topic
Leukemia, MyeloidMajor topic
MonocytesMajor topic
Receptors, ImmunologicMajor topic
Antibodies, Monoclonal
Cell Differentiation
Cell Division
Cell Line
Humans
Receptors, Interleukin-2
T-Lymphocytes

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA19389NCI NIH HHSUnited StatesR01CA019389PubMed and NIHNIH RePORTER
CA36167NCI NIH HHSUnited StatesR01CA036167PubMed and NIHNIH RePORTER
R37CA036167NIHNIH RePORTER

Download CSV of grants

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16970774A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.J Immunol1981https://conductscience.org/library/papers/6970774PubMed
26952949Isolation of myeloid progenitor cells from peripheral blood of chronic myelogenous leukemia patients.Blood1982https://conductscience.org/library/papers/6952949PubMed
36287286Prostaglandins modulate macrophage Ia expression.Nature1982https://conductscience.org/library/papers/6287286PubMed
46193183Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.J Immunol1983https://conductscience.org/library/papers/6193183PubMed
52578045Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations.J Immunol1985https://conductscience.org/library/papers/2578045PubMed
66205075Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.J Immunol1984https://conductscience.org/library/papers/6205075PubMed
76092511Expression of interleukin 2 receptors on activated human B cells.J Exp Med1984https://conductscience.org/library/papers/6092511PubMed
86092512Detection and functional studies of p60-65 (Tac antigen) on activated human B cells.J Exp Med1984https://conductscience.org/library/papers/6092512PubMed
93917277MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.J Immunol1985https://conductscience.org/library/papers/3917277PubMed
106417261Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway.J Exp Med1983https://conductscience.org/library/papers/6417261PubMed

Download CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 309 citations.

PMIDTitleJournalYearIn PapersSource
42353571In Vitro Effects of the Three Actives IL-12 (5 CH), IFN-γ (6 CH), and TNF-α (5 CH) from the Micro-Immunotherapy Medicine 2LEID-N® on Several Populations of Immune Cells.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42353571PubMed
41514929Phenotypic Profiling and Activation-Associated Expression of CD99 Ligands on Human Leukocytes.Biology (Basel)2025https://conductscience.org/library/papers/41514929PubMed
40507248Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8.Cancers (Basel)2025https://conductscience.org/library/papers/40507248PubMed
40337274A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythematosus.Front Med (Lausanne)2025https://conductscience.org/library/papers/40337274PubMed
32764489
Therapeutic Zfra4-10 or WWOX7-21 Peptide Induces Complex Formation of WWOX with Selective Protein Targets in Organs that Leads to Cancer Suppression and Spleen Cytotoxic Memory Z Cell Activation In Vivo.
Cancers (Basel)2020https://conductscience.org/library/papers/32764489PubMed
27746745Pressure Induced Changes in Adaptive Immune Function in Belugas (Delphinapterus leucas); Implications for Dive Physiology and Health.Front Physiol2016https://conductscience.org/library/papers/27746745PubMed
26984209Novel TNF-related Apoptotic-inducing Ligand-based Immunotoxin for Therapeutic Targeting of CD25 Positive Leukemia.Target Oncol2016https://conductscience.org/library/papers/26984209PubMed
22530792Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes.BMC Gastroenterol2012https://conductscience.org/library/papers/22530792PubMed
18475735Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.Mediators Inflamm1996https://conductscience.org/library/papers/18475735PubMed
18475504Suppression of monocyte and neutrophil function by recombinant IL-2.Mediators Inflamm1993https://conductscience.org/library/papers/18475504PubMed
18475497Biological significance of soluble IL-2 receptor.Mediators Inflamm1993https://conductscience.org/library/papers/18475497PubMed
17216565Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.J Clin Immunol2007https://conductscience.org/library/papers/17216565PubMed
9685859Inhibition by sphingosine of leukemic cell killing by human monocytes activated with interleukin-2: a possible role of protein kinase C.Jpn J Cancer Res1998https://conductscience.org/library/papers/9685859PubMed
8878609Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8878609PubMed
8755561An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8755561PubMed
8698622Rejection of mouse renal cell carcinoma elicited by local secretion of interleukin-2.Jpn J Cancer Res1996https://conductscience.org/library/papers/8698622PubMed
8645743LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.Ann Hematol1996https://conductscience.org/library/papers/8645743PubMed
8311539Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.Ann Rheum Dis1993https://conductscience.org/library/papers/8311539PubMed
8039809
Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production.
Immunology1994https://conductscience.org/library/papers/8039809PubMed
8003557Induction of soluble IL-2 receptor in patients with myelodysplastic syndromes undergoing high-dose interleukin-3 treatment.Ann Hematol1994https://conductscience.org/library/papers/8003557PubMed

See all 66 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RB3560PubTator's text mininghttps://conductscience.org/library/genes/3560NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3928803

GET https://conductscience.org/api/papers/v1/3928803/cited_by?page=2